Breathing is life, but for millions of people living with lung diseases, each breath can be a constant struggle. These…
Lung cancer
The combination of the antibody amivantamab and lazertinib, a drug targeting EGFR, shows better clinical benefits compared to standard treatment…
Honoring the legacy of Heine Hoi Hansen and his global contribution to lung cancer research and education, the Heine H….
Inaugurated by Andrés Cervantes (Valencia, Spain), President of the European Society for Medical Oncology (ESMO) and ESMO Congress 2023, this…
Results of exploratory analysis of overall survival data from the pivotal phase III IMpower010 study were presented on the ground…
Mutations in the TP53 tumor suppressor gene occur in 50% of lung adenocarcinoma and associate with a poor prognosis, but…
Dr Enriqueta Felip, head of the Thoracic Tumours and Head and Neck Cancer Group at VHIO and section head in…
Reflective of the relevance of just some of the many VHIO-led studies presented during last week’s virtual 2021 Annual Congress…
Featuring among our pre-selection pick of VHIO (co) led research (1) that has subsequently headlined during this week’s virtual 2021 annual Congress of…
